Berenberg Bank Reiterates Buy Rating for Advanced Medical Solutions Group (LON:AMS)

Advanced Medical Solutions Group (LON:AMS)‘s stock had its “buy” rating restated by equities research analysts at Berenberg Bank in a note issued to investors on Wednesday, MarketBeat Ratings reports. They presently have a GBX 300 ($3.90) price objective on the stock. Berenberg Bank’s price target indicates a potential upside of 45.29% from the stock’s previous close.

Advanced Medical Solutions Group Stock Performance

Shares of AMS stock opened at GBX 206.48 ($2.68) on Wednesday. Advanced Medical Solutions Group has a one year low of GBX 176.60 ($2.30) and a one year high of GBX 275.83 ($3.59). The company’s 50-day moving average is GBX 211.07 and its 200 day moving average is GBX 213.11. The company has a debt-to-equity ratio of 37.01, a quick ratio of 4.58 and a current ratio of 8.39. The company has a market capitalization of £445.84 million, a price-to-earnings ratio of 40.01, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.